HQY — HealthEquity Cashflow Statement
0.000.00%
Last trade - 00:00- $7.43bn
- $8.19bn
- $1.20bn
- 87
- 25
- 68
- 62
Annual cashflow statement for HealthEquity, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 8.83 | -44.3 | -26.1 | 55.7 | 96.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 49.7 | 69.9 | 66.1 | 81.2 | 100 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 12.3 | 1.63 | -33.4 | -33.1 | -6.53 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 182 | 141 | 151 | 243 | 340 |
| Capital Expenditures | -97 | -137 | -119 | -46.1 | -505 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 0 | -502 | 0 | 0 | — |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -97 | -639 | -119 | -46.1 | -505 |
| Financing Cash Flow Items | -3.86 | -18.4 | -0.603 | 0.865 | -5.37 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 52.4 | 395 | -2.67 | -47 | 57.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 137 | -103 | 28.9 | 150 | -108 |